A phase III trial of revamilast in patients with asthma or rheumatoid arthritis.

Trial Profile

A phase III trial of revamilast in patients with asthma or rheumatoid arthritis.

Planning
Phase of Trial: Phase III

Latest Information Update: 10 Aug 2011

At a glance

  • Drugs Revamilast (Primary)
  • Indications Asthma; Rheumatoid arthritis
  • Focus Registrational; Therapeutic Use
  • Sponsors Glenmark Pharmaceuticals Ltd
  • Most Recent Events

    • 10 Aug 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top